Dr Peters current work is focused on use of different antihypertensives, frailty and risk and benefit of treatment in the very elderly.
Between 2010 and 2012 Dr Peters was part of the core team setting up and developing the Imperial Clinical Trials Unit (ICTU). ICTU was launched in 2010 and is a fully UKCRC registered trials unit.
Prior to 2010 she led the multinational HYpertension in the Very Elderly Trial Cognitve function (HYVET-COG) study and co-ordinated the main Hypertension in the Very Elderly [HYVET] trial. HYVET was an Imperial sponsored multinational double blind RCT which was rated ‘Trial of the year’ by the Society for Clinical Trials and an exceptional landmark in medicine(F1000) in 2008. The HYVET trial results have changed global guidelines for the use of antihypertensive treatment in older adults (>=80 years).
Research interests include risk factors for dementia, particularly cardiovascular risk factors and potential interventions to ameliorate or prevent cognitive decline and dementia.
et al., 2023, Higher systolic blood pressure in early-mid adulthood is associated with poorer cognitive performance in those with a dominantly inherited Alzheimer's disease mutation but not in non-carriers. Results from the DIAN study., Alzheimers Dement
et al., 2023, Testing times for dementia: a community survey identifying contemporary barriers to risk reduction and screening., Alzheimers Res Ther, Vol:15
et al., 2023, Frequency of coexistent eye diseases and cognitive impairment or dementia: a systematic review and meta-analysis, Eye, ISSN:0950-222X
et al., 2023, What would a population-level approach to dementia risk reduction look like, and how would it work?, Alzheimers & Dementia, ISSN:1552-5260
Peters R, Anderson C, 2023, BLOOD PRESSURE, ANTIHYPERTENSIVES AND DEMENTIA, AN INDIVIDUAL PATIENT DATA META-ANALYSIS, LIPPINCOTT WILLIAMS & WILKINS, Pages:E15-E16, ISSN:0263-6352